Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Kunishima H"" wg kryterium: Wszystkie pola


Tytuł:
First nationwide survey of infection prevention and control among healthcare facilities in Japan: impact of the national regulatory system.
Autorzy:
Nomoto H; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.; Emerging and Re-emerging Infectious Diseases, Graduate School of Medicine, Tohoku University, Miyagi, Japan.
Saito H; Faculty of Medicine, Institute of Global Health, University of Geneva, Geneva, Switzerland.; Department of Emergency and Critical Care Medicine, St. Marianna University School of Medicine Yokohama Seibu Hospital, Kanagawa, Japan.; AMR Clinical Reference Center, National Center for Global Health and Medicine, Tokyo, Japan.
Ishikane M; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan. .; AMR Clinical Reference Center, National Center for Global Health and Medicine, Tokyo, Japan. .
Gu Y; Department of Infectious Diseases, Tokyo Medical and Dental University, Tokyo, Japan.
Ohmagari N; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.; Emerging and Re-emerging Infectious Diseases, Graduate School of Medicine, Tohoku University, Miyagi, Japan.; AMR Clinical Reference Center, National Center for Global Health and Medicine, Tokyo, Japan.
Pittet D; Infection Control Programme, University of Geneva Hospitals and Faculty of Medicine, Geneva, Switzerland.
Kunishima H; Department of Infectious Diseases, St Marianna University School of Medicine, Kanagawa, Japan.
Allegranzi B; Infection Prevention and Control Hub, Integrated Health Services, World Health Organization, Geneva, Switzerland.
Yoshida M; Department of Infectious Diseases and Infection Control, The Jikei University School of Medicine, Tokyo, Japan.
Pokaż więcej
Źródło:
Antimicrobial resistance and infection control [Antimicrob Resist Infect Control] 2022 Nov 09; Vol. 11 (1), pp. 135. Date of Electronic Publication: 2022 Nov 09.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Infection Control*
Cross Infection*/prevention & control
Humans ; Cross-Sectional Studies ; Japan ; Delivery of Health Care
Czasopismo naukowe
Tytuł:
Predicting the aggravation of coronavirus disease-19 pneumonia using chest computed tomography scans.
Autorzy:
Yamasaki Y; Department of Infectious Diseases, St. Marianna University School of Medicine, Miyamae-ku, Kawasaki, Kanagawa, Japan.
Ooka S; Division of Rheumatology and Allergology, Department of Internal Medicine, St. Marianna University School of Medicine, Miyamae-ku, Kawasaki, Kanagawa, Japan.
Matsuoka S; Department of Radiology, St. Marianna University School of Medicine, Miyamae-ku, Kawasaki, Kanagawa, Japan.
Tomita H; Department of Radiology, St. Marianna University School of Medicine, Miyamae-ku, Kawasaki, Kanagawa, Japan.
Hirose M; Division of General Internal Medicine, Department of Internal Medicine, St. Marianna University School of Medicine, Miyamae-ku, Kawasaki, Kanagawa, Japan.
Takano T; Department of Infectious Diseases, St. Marianna University School of Medicine, Miyamae-ku, Kawasaki, Kanagawa, Japan.
Suzuki S; Division of Rheumatology and Allergology, Department of Internal Medicine, St. Marianna University School of Medicine, Miyamae-ku, Kawasaki, Kanagawa, Japan.
Imamura M; Division of Rheumatology and Allergology, Department of Internal Medicine, St. Marianna University School of Medicine, Miyamae-ku, Kawasaki, Kanagawa, Japan.
Handa H; Division of Respiratory Disease, Department of Internal Medicine, St. Marianna University School of Medicine, Miyamae-ku, Kawasaki, Kanagawa, Japan.
Nishine H; Division of Respiratory Disease, Department of Internal Medicine, St. Marianna University School of Medicine, Miyamae-ku, Kawasaki, Kanagawa, Japan.
Takita M; Department of Emergency and Critical Care Medicine, St. Marianna University School of Medicine, Miyamae-ku, Kawasaki, Kanagawa, Japan.
Minoura A; Department of Emergency and Critical Care Medicine, St. Marianna University School of Medicine, Miyamae-ku, Kawasaki, Kanagawa, Japan.
Morisawa K; Department of Emergency and Critical Care Medicine, St. Marianna University School of Medicine, Miyamae-ku, Kawasaki, Kanagawa, Japan.
Inoue T; Division of Respiratory Disease, Department of Internal Medicine, St. Marianna University School of Medicine, Miyamae-ku, Kawasaki, Kanagawa, Japan.
Mineshita M; Division of Respiratory Disease, Department of Internal Medicine, St. Marianna University School of Medicine, Miyamae-ku, Kawasaki, Kanagawa, Japan.
Kawahata K; Division of Rheumatology and Allergology, Department of Internal Medicine, St. Marianna University School of Medicine, Miyamae-ku, Kawasaki, Kanagawa, Japan.
Takemura H; Department of Microbiology, St. Marianna University School of Medicine, Miyamae-ku, Kawasaki, Kanagawa, Japan.
Fujitani S; Department of Emergency and Critical Care Medicine, St. Marianna University School of Medicine, Miyamae-ku, Kawasaki, Kanagawa, Japan.
Kunishima H; Department of Infectious Diseases, St. Marianna University School of Medicine, Miyamae-ku, Kawasaki, Kanagawa, Japan.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2022 Nov 03; Vol. 17 (11), pp. e0276738. Date of Electronic Publication: 2022 Nov 03 (Print Publication: 2022).
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*/diagnostic imaging
Humans ; SARS-CoV-2 ; Tomography, X-Ray Computed/methods ; Lung/diagnostic imaging ; Hypoxia ; Retrospective Studies
Czasopismo naukowe
Tytuł:
A Case of Exacerbation of Haloperidol-Induced Rhabdomyolysis Following the Onset of COVID-19.
Autorzy:
Takada K; Department of Pharmacy, Yokohama General Hospital, Yokohama, Kanagawa, Japan.
Sada Y; Department of Internal Medicine, Yokohama General Hospital, Yokohama, Kanagawa, Japan.
Samura M; Department of Pharmacy, Yokohama General Hospital, Yokohama, Kanagawa, Japan.
Matsuura M; Department of Pharmacy, Yokohama General Hospital, Yokohama, Kanagawa, Japan.
Hirose N; Department of Pharmacy, Yokohama General Hospital, Yokohama, Kanagawa, Japan.
Kurata T; Department of Pharmacy, Yokohama General Hospital, Yokohama, Kanagawa, Japan.
Nagumo F; Department of Pharmacy, Yokohama General Hospital, Yokohama, Kanagawa, Japan.
Ishii J; Department of Pharmacy, Yokohama General Hospital, Yokohama, Kanagawa, Japan.
Koshioka S; Department of Pharmacy, Yokohama General Hospital, Yokohama, Kanagawa, Japan.
Uchida M; Department of Pharmacy, Yokohama General Hospital, Yokohama, Kanagawa, Japan.
Inoue J; Department of Pharmacy, Yokohama General Hospital, Yokohama, Kanagawa, Japan.
Tanikawa K; Department of Pharmacy, Yokohama General Hospital, Yokohama, Kanagawa, Japan.
Kunishima H; Department of Infectious Diseases, St. Marianna University School of Medicine Hospital, Kawasaki, Kanagawa, Japan.
Pokaż więcej
Źródło:
The American journal of case reports [Am J Case Rep] 2022 Jun 20; Vol. 23, pp. e936589. Date of Electronic Publication: 2022 Jun 20.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Acute Kidney Injury*/etiology
COVID-19*
Rhabdomyolysis*/etiology
Haloperidol/adverse effects ; Hematuria ; Humans ; Male ; Middle Aged
Czasopismo naukowe
Tytuł:
COVID-19 and adult-onset Still's disease as part of hyperferritinemic syndromes.
Autorzy:
Kawasaki T; Division of Rheumatology and Allergology, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan.
Ooka S; Division of Rheumatology and Allergology, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan.
Mizushima M; Division of Rheumatology and Allergology, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan.
Nakamura Y; Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan.
Ikeda H; Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan.
Sakurada T; Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan.
Suzuki S; Division of Rheumatology and Allergology, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan.
Yamazaki K; Division of Rheumatology and Allergology, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan.
Goto Y; Division of Rheumatology and Allergology, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan.
Sakurai K; Division of Rheumatology and Allergology, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan.
Yukitaka Y; Department of Infectious Diseases, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan.
Kiyokawa T; Division of Rheumatology and Allergology, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan.
Tonooka K; Division of Rheumatology and Allergology, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan.
Kunishima H; Department of Infectious Diseases, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan.
Kawahata K; Division of Rheumatology and Allergology, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan.
Pokaż więcej
Źródło:
Modern rheumatology case reports [Mod Rheumatol Case Rep] 2022 Jan 07; Vol. 6 (1), pp. 101-105.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
COVID-19*/diagnosis
Macrophage Activation Syndrome*/diagnosis
Macrophage Activation Syndrome*/drug therapy
Still's Disease, Adult-Onset*/diagnosis
Still's Disease, Adult-Onset*/drug therapy
COVID-19 Drug Treatment*
Adult ; Antibodies, Monoclonal, Humanized/therapeutic use ; Ferritins ; Humans ; Prednisolone/therapeutic use
Czasopismo naukowe
Tytuł:
Efficacy and Safety of Favipiravir in Moderate COVID-19 Pneumonia Patients without Oxygen Therapy: A Randomized, Phase III Clinical Trial.
Autorzy:
Shinkai M; Department of Respiratory Medicine, Tokyo Shinagawa Hospital, 6-3-22 Higashioi, Shinagawa-ku, Tokyo, 140-8522, Japan.
Tsushima K; Department of Pulmonary Medicine, School of Medicine, International University of Health and Welfare, 852 Hatakeda, Narita, Chiba, 286-8520, Japan.
Tanaka S; Department of Otolaryngology, Self-Defense Forces Central Hospital, 1-2-24 Ikejiri, Setagaya-ku, Tokyo, 154-8532, Japan.
Hagiwara E; Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, 6-16-1 Tomiokahigashi, Kanazawa-ku, Yokohama, Kanagawa, 236-0051, Japan.
Tarumoto N; Department of Infectious Disease and Infection control, Saitama Medical University Hospital, 38 Morohongo, Moroyama-machi, Iruma-gun, Saitama, 350-0495, Japan.
Kawada I; Division of Pulmonary Medicine, Department of Medicine, School of Medicine, Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan.
Hirai Y; Department of Infectious Diseases, Tokyo Medical University Hachioji Medical Center, 1163 Tatemachi, Hachioji, Tokyo, 193-0998, Japan.
Fujiwara S; Department of Infectious Diseases, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, 3-18-22 Honkomagome, Bunkyo-ku, Tokyo, 113-8677, Japan.
Komase Y; Department of Respiratory Internal Medicine, St. Marianna University Yokohama City Seibu Hospital, 1197-1 Yasashi-cho, Asahi-ku, Yokohama, Kanagawa, 241-0811, Japan.
Saraya T; Department of Respiratory Medicine, Kyorin University School of Medicine, 6-20-2 Shinkawa, Mitaka, Tokyo, 181-8611, Japan.
Koh H; Division of Pulmonary Medicine, Department of Internal Medicine, Tachikawa Hospital, 4-2-22 Nishiki-cho, Tachikawa, Tokyo, 190-8531, Japan.
Kagiyama N; Department of Respiratory Medicine, Saitama Cardiovascular and Respiratory Center, 1696 Itai, Kumagaya, Saitama, 360-0197, Japan.
Shimada M; Department of General Internal Medicine, Tokai University Oiso Hospital, 21-1 Gakkyo, Oiso-machi, Naka-gun, Kanagawa, 259-0198, Japan.
Kanou D; Department of Respiratory Internal Medicine, Yokohama Rosai Hospital, 3211 Kozukue-cho, Kohoku-ku, Yokohama, Kanagawa, 222-0036, Japan.
Antoku S; Department of Diabetes, Metabolism and Kidney Disease, Edogawa Hospital, 2-24-18 Higashikoiwa, Edogawa-ku, Tokyo, 133-0052, Japan.
Uchida Y; Department of General Medicine, Kitakyushu Municipal Medical Center, 2-1-1 Bashaku, Kokurakita-ku, Kitakyushu, Fukuoka, 802-8561, Japan.
Tokue Y; Infection Control and Prevention Center, Gunma University Hospital, 3-39-15 Showamachi, Maebashi, Gunma, 371-8511, Japan.
Takamori M; Department of Respiratory Medicine, Tokyo Metropolitan Tama Medical Center, 2-8-29 Musashidai, Fuchu, Tokyo, 183-8524, Japan.
Gon Y; Department of Respiratory Medicine, Nihon University Itabashi Hospital, 30-1 Oyaguchikami-cho, Itabashi-ku, Tokyo, 173-8610, Japan.
Ie K; Department of General Internal Medicine, Kawasaki Municipal Tama Hospital, 1-30-37 Shukugawara, Tama-ku, Kawasaki, Kanagawa, 214-8525, Japan.
Yamazaki Y; Department of Respiratory and Infectious Diseases, Nagano Prefectural Shinshu Medical Center, 1332 Suzaka, Suzaka, Nagano, 382-8577, Japan.
Harada K; Department of Cardiology, Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology, 35-2 Sakae-cho, Itabashi-ku, Tokyo, 173-0015, Japan.
Miyao N; Department of Internal Medicine, Nippon Koukan Hospital, 1-2-1 Kokandori, Kawasaki-ku, Kawasaki, Kanagawa, 210-0852, Japan.
Naka T; Department of Neurology, Higashiosaka City Medical Center, 3-4-5 Nishiiwata, Higashiosaka, Osaka, 578-8588, Japan.
Iwata M; Department of Emergency and General Internal Medicine, Fujita Health University Hospital, 1-98 Dengakugakubo, Kutsukake-cho, Toyoake, Aichi, 470-1192, Japan.
Nakagawa A; Department of Respiratory Medicine, Kobe City Medical Center General Hospital, 2-1-1 Minatojimaminamimachi, Chuo-ku, Kobe, Hyogo, 650-0047, Japan.
Hiyama K; Department of Infectious Diseases, National Hospital Organization Fukuokahigashi Medical Center, 1-1-1 Chidori, Koga, Fukuoka, 811-3195, Japan.
Ogawa Y; Department of Infectious Diseases, Sakai City Medical Center, 1-1-1 Ebarajicho, Nishi-ku, Sakai, Osaka, 593-8304, Japan.
Shinoda M; Department of Respiratory Medicine, Tokyo Shinagawa Hospital, 6-3-22 Higashioi, Shinagawa-ku, Tokyo, 140-8522, Japan.
Ota S; Department of Respiratory Medicine, Tokyo Shinagawa Hospital, 6-3-22 Higashioi, Shinagawa-ku, Tokyo, 140-8522, Japan.
Hirouchi T; Department of Respiratory Medicine, Tokyo Shinagawa Hospital, 6-3-22 Higashioi, Shinagawa-ku, Tokyo, 140-8522, Japan.
Terada J; Department of Pulmonary Medicine, School of Medicine, International University of Health and Welfare, 852 Hatakeda, Narita, Chiba, 286-8520, Japan.
Kawano S; Department of Internal Medicine, Self-Defense Forces Central Hospital, 1-2-24 Ikejiri, Setagaya-ku, Tokyo, 154-8532, Japan.
Ogura T; Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, 6-16-1 Tomiokahigashi, Kanazawa-ku, Yokohama, Kanagawa, 236-0051, Japan.
Sakurai T; Scientific Information Department, FujiFilm Toyama Chemical Co., Ltd., 3-4-8 Hatchobori, Chuo-ku, Tokyo, 104-0032, Japan.
Matsumoto Y; Scientific Information Department, FujiFilm Toyama Chemical Co., Ltd., 3-4-8 Hatchobori, Chuo-ku, Tokyo, 104-0032, Japan.
Kunishima H; Department of Infectious Diseases, School of Medicine, St. Marianna University, 2-16-1 Sugao, Miyamae-ku, Kawasaki, Kanagawa, 216-8511, Japan.
Kobayashi O; Department of Infectious Diseases, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
Iwata S; Department of Infectious Diseases, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan. .
Pokaż więcej
Źródło:
Infectious diseases and therapy [Infect Dis Ther] 2021 Dec; Vol. 10 (4), pp. 2489-2509. Date of Electronic Publication: 2021 Aug 27.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Why participation in an international clinical trial platform matters during a pandemic? Launching REMAP-CAP in Japan.
Autorzy:
Kamata K; Department of General Internal Medicine, Aizu Medical Center, Fukushima Medical University, 21-2 Maeda, Kawahigashimachi Tanisawa, Aizuwakamatsu-city, Fukushima, 969-3492, Japan.; Department of Pediatrics, Graduate School of Medical and Dental Sciences, Niigata University, 1-757 Asahimachi-dori, Chuo-ku, Niigata, 951-8510, Niigata city, Japan.
Jindai K; Department of Healthcare Epidemiology, School of Public Health, Kyoto University, Yoshida-konoe-cho, Sakyo-Ku, Kyoto-city, Kyoto, 606-8501, Japan. .
Ichihara N; Department of Healthcare Quality Assessment, Graduate School of Medicine, The University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.
Saito H; Department of Emergency and Critical Care Medicine, St. Marianna University School of Medicine, Yokohama City Seibu Hospital, 1197-1 Yasashicho, Asahi-ku, Yokohama-city, Kanagawa, 241-0811, Japan.
Kato H; Infection Prevention and Control Department, Yokohama City University Hospital, 3-9 Fukuura, Kanazawa-ku, Yokohama-city, Kanagawa, 236-0004, Japan.
Kunishima H; Department of Infectious Diseases, St. Marianna University School of Medicine, 2-16-1 Sugao, Miyamae-ku, Kawasaki-city, Kanagawa, 216-8511, Japan.
Shintani A; Department of Medical Statistics, Graduate School of Medicine, Osaka City University, 1-4-3 Asahi-machi, Abeno-ku, Osaka-City, Osaka, 545-0051, Japan.
Nishida O; Department of Anesthesiology and Critical Care Medicine, School of Medicine, Fujita Health University, 1-98 Dengakugakubo, Kutsukake-cho, Toyoake-city, Aichi, 470-1192, Japan.
Fujitani S; Department of Emergency and Critical Care Medicine, St. Marianna University School of Medicine, 2-16-1 Sugao, Miyamae-ku, Kawasaki-city, Kanagawa, 216-8511, Japan.
Pokaż więcej
Źródło:
Journal of intensive care [J Intensive Care] 2021 Apr 14; Vol. 9 (1), pp. 34. Date of Electronic Publication: 2021 Apr 14.
Typ publikacji:
Letter
Opinia redakcyjna

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies